The Institute of Bioengineering and Nanotechnology (IBN), a research body under A*Star, has teamed up with a Japanese medical technology company to set up a research centre here.
Arkray will invest $9.1 million in the centre over a five-year period and leverage on IBN's expertise to develop novel detection kits for infectious diseases.